Ligand (LGND): Sotuvning sof marjinal rentabelligi

Ligand Pharmaceuticals Incorporated (LGND) korporativ emblemasi va logotipi

Ligand Pharmaceuticals (LGND) avtomatlashtirish orqali xodimlarning sonini kamaytirgan holda, uchinchi tomon ishlab chiqaruvchilardan olinadigan royalti to'lovlari orqali daromad keltiradi. GURU.Markets platformasida sof foyda marjasi joriy tendentsiyani aks ettiradi, bunda 20.30 qiymati haqiqiy raqamni ko'rsatadi. AI skriningi va nanotexnologiyalar sohasidagi ishlanmalar samaradorlikni oshirmoqda, ventura investitsiyalarining kengaytirilishi esa operatsion xarajatlarni oshirmasdan foyda o'sishini ta'minlaydi.

Ligand Corp (LGND) Sotuvning sof rentabelligi: 04.07.2022 - 20.11.2026 davri uchun

Ligand Corp (LGND) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning umumiy tahlili:Ligand - LGND
Ligand Pharma tayyor mahsulotlari

Ushbu ko'rsatkich sof foydaning umumiy tushumdagi ulushini o'lchaydi, bu esa investorlarga oraliq hisobot davrlari mobaynida operatsion daromadning real kapitalga aylanish samaradorligini baholash imkonini beradi. Sof foyda marjasi tahlili Ligand Pharmaceuticals (LGND) kompaniyasining sog'liqni saqlash gigantlari bilan hamkorlik modelining barqarorligini tasdiqlaydi hamda qo'shma ishlanmalar marjalarni qanchalik samarali kengaytirishi va aktivning fundamental qiymatini tasdiqlashini namoyish etadi.

Ligand Pharmaceuticals kimlar bilan raqobatlashadi

HLN: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi KVUE|Sof marja veronapharma.com|Sotuvning sof rentabelligi MENS (Jyong Biotech Corp)|Sotuvning sof marjinal rentabelligi AMRX|Kompaniya sotuv marjasi Perrigo Company plc|Sotuvning sof marjinal rentabelligi ALVO (Alvotech Biopharmaceuticals)|LQDA: Sotuvning sof rentabelligi|Galapagos N.V. - Sotuvning sof marjinal rentabelligi|ANIP - Sotuvning sof marjinal rentabelligi|MNKD: Sotuvning sof marjinal rentabelligi|amphastar.com (AMPH) - Sotuvning sof marjinal rentabelligi|PCRX (Pacira Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ARS Pharmaceuticals, Inc. (SPRY)|Sotuvning sof marjinal rentabelligi TBPH|AQST (Aquestive Therapeutics) - Sof foyda normasi|scPharmaceuticals, Inc. - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi TECX|tonixpharma.com - Sotuvning sof marjinal rentabelligi|Sof foyda normasi SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi BioHarvest|Sof foyda bo'yicha sotuv rentabelligi EXOZ|Sof foyda bo'yicha sotuv rentabelligi Oramed Pharmaceuticals (ORMP)|Sof foyda bo'yicha sotuv rentabelligi ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi ABVC (ABVC BioPharma Inc)|CPIX - Sof foyda bo'yicha sotuv rentabelligi|Quantum BioPharma Corp - Sotuvning sof marjinal rentabelligi|FGEN (fibrogen.com) - Sotuvning sof rentabelligi|TELO (Telomir Pharmaceuticals) - Sof foyda bo'yicha sotuv rentabelligi|Rani Therapeutics Holdings - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi SNYR|Sof marja rallybio.com RLYB|Sotuvning sof marjinal rentabelligi LEXX|PULM (Pulmatrix, Inc.) - Sof foyda normasi|Pheton Holdings - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Aptorum Group Limited APM|LYRA: Sof foyda bo'yicha sotuv rentabelligi|IBO: Sof marja|TNFA: Sotuvning sof marjinal rentabelligi|YCBD: Kompaniyaning sof rentabelligi|Sof marja PainReform Ltd|CYTO (altamiratherapeutics.com) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi LIPO|OPTN - Sof marja|Sof marja pieris.com PIRS|Sof foyda normasi PROC|PTPI - Sof marja|Qilian International Holding (QLI) - Sof foyda bo'yicha sotuv rentabelligi|SLRN: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi TFF Pharma